Evidence map›Paper›PMID 31747074›Full record

ArticleThe British journal of surgery2019

Radiomics approach to distinguish between well differentiated liposarcomas and lipomas on MRI.

M Vos, M P A Starmans, M J M Timbergen, S R van der Voort, G A Padmos, W Kessels, W J Niessen, G J L H van Leenders, D J Grünhagen, S Sleijfer and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

M VosDepartment of Medical, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.ORCID 0000-0001-6238-8643
M P A StarmansDepartment of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.ORCID 0000-0001-5086-7153
M J M TimbergenDepartment of Medical, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
S R van der VoortDepartment of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
G A PadmosDepartment of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
W KesselsDepartment of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
W J NiessenDepartment of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
G J L H van LeendersDepartment of Pathology, Erasmus MC, Rotterdam, the Netherlands.
D J GrünhagenDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
S SleijferDepartment of Medical, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
C VerhoefDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
S KleinDepartment of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
J J VisserDepartment of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
Erasmus MC · NLErasmus MC Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWell differentiated liposarcoma (WDLPS) can be difficult to distinguish from lipoma. Currently, this distinction is made by testing for MDM2 amplification, which requires a biopsy. The aim of this study was to develop a noninvasive method to predict MDM2 amplification status using radiomics features derived from MRI.

methodsPatients with an MDM2-negative lipoma or MDM2-positive WDLPS and a pretreatment T1-weighted MRI scan who were referred to Erasmus MC between 2009 and 2018 were included. When available, other MRI sequences were included in the radiomics analysis. Features describing intensity, shape and texture were extracted from the tumour region. Classification was performed using various machine learning approaches. Evaluation was performed through a 100 times random-split cross-validation. The performance of the models was compared with the performance of three expert radiologists.

resultsThe data set included 116 tumours (58 patients with lipoma, 58 with WDLPS) and originated from 41 different MRI scanners, resulting in wide heterogeneity in imaging hardware and acquisition protocols. The radiomics model based on T1 imaging features alone resulted in a mean area under the curve (AUC) of 0·83, sensitivity of 0·68 and specificity of 0·84. Adding the T2-weighted imaging features in an explorative analysis improved the model to a mean AUC of 0·89, sensitivity of 0·74 and specificity of 0·88. The three radiologists scored an AUC of 0·74 and 0·72 and 0·61 respectively; a sensitivity of 0·74, 0·91 and 0·64; and a specificity of 0·55, 0·36 and 0·59.

conclusionRadiomics is a promising, non-invasive method for differentiating between WDLPS and lipoma, outperforming the scores of the radiologists. Further optimization and validation is needed before introduction into clinical practice.

Indexed as

AgedDiagnosis, DifferentialFemaleHumansLipomaLiposarcomaMagnetic Resonance ImagingMaleMiddle AgedRadiographic Image Interpretation, Computer-AssistedReproducibility of ResultsSensitivity and Specificity

Identifiers

PMID31747074
PMCPMC6899528
OpenAlexW2990601131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.